In Czechia, data on drug-related infections are available from national registers and studies involving different drug user groups. These data indicate that the rates of human immunodeficiency virus (HIV) infection/acquired immunodeficiency syndrome (AIDS), hepatitis B virus (HBV) infection and hepatitis C virus (HCV) infection among drug users have remained stable in recent years.
|Data from 2016 (HIV) and from 2017 (HCV).|
|National||14.7||0.0 - 0.1|
The number of newly diagnosed HIV-positive people among the general population is relatively low, with transmission among men who have sex with men identified as the dominant route overall. HIV seroprevalence rates among people who inject drugs (PWID) also remain low. The number of newly reported cases of acute HBV infection continues to decline. This is attributed to the routine vaccination programme for the general population introduced in 2001. In Czechia, more than half of newly reported cases of HCV infection in which the transmission route is known are in PWID. The latest available data from low-threshold facilities suggest that fewer than one in five clients of needle exchange programmes tested in these facilities were positive for HCV antibodies. A seroprevalence study among PWID is being conducted to provide a representative estimate.
Available data indicate that methamphetamine is the most prevalent injected drug in Czechia and that more than half of those who have ever injected drugs have shared their injecting equipment with peers.